https://www.selleckchem.com/pr....oducts/mi-773-sar405
in OS patients. • Peritumoral MRI parameters can predict EFS and overall survival in OS patients. • MRI parameters may be predictive factors for evaluating chemotherapy efficacy and EFS. • Peritumoral MRI parameters can reflect the chemotherapy response in OS patients. • Peritumoral MRI parameters can predict EFS and overall survival in OS patients. • MRI parameters may be predictive factors for evaluating chemotherapy efficacy and EFS. To develop a nomogram to identify anaplastic lymphoma kinase (ALK) mutations in lung adenoca
Like
Comment
Share
